Psychiatry and Neurology, Neurology · Kansas City, KS
NPI
1730288143
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
3901 Rainbow Blvd, 4070 Delp Mail Stop 4017
Kansas City, KS, 66160
Phone (913) 588-6970
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
749 services
Medicare patients, 2024
302
Average age 66
Drug cost, 2024
$5.6M
5,530 prescriptions
Company payments, 2025
$219
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sharon G Lynch was code 99214 (office e&m - established), 323 times for 226 patients. In total Sharon G Lynch billed 749 services in 10 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 323 | 226 | $61.62 | $20K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 287 | 227 | $11.60 | $3,329 |
| 99215 Office E&M - Established | Office | 51 | 47 | $106.18 | $5,415 |
| 99213 Office E&M - Established | Office | 45 | 43 | $40.40 | $1,818 |
| 99205 Office E&M - New | Office | 23 | 23 | $134.62 | $3,096 |
By year: 2022 $30K for 495 services; 2023 $30K for 461 services; 2024 $34K for 749 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sharon G Lynch prescribed most often to Medicare patients was Baclofen, with 628 prescriptions and refills. In total Sharon G Lynch wrote 5,530 Medicare prescriptions that cost $5.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 628 | 1,278 | 157 | $21K |
| Gabapentin Generic | 512 | 862 | 109 | $11K |
| Dalfampridine Er Dalfampridine | 386 | 411 | 51 | $60K |
| Tizanidine Hcl Generic | 212 | 378 | 47 | $4,248 |
| Diazepam Generic | 168 | 196 | 32 | $913 |
| Duloxetine Hcl Generic | 147 | 284 | 26 | $2,327 |
| Teriflunomide Generic | 139 | 141 | 20 | $16K |
| Oxybutynin Chloride Generic | 131 | 280 | 34 | $3,139 |
| Fingolimod Fingolimod Hcl | 118 | 126 | 14 | $203K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 115 | 115 | 14 | $2,096 |
| Copaxone Glatiramer Acetate | 99 | 99 | Under 11 | $543K |
| Clonazepam Generic | 92 | 117 | 12 | $755 |
| Kesimpta Pen Ofatumumab | 92 | 102 | Under 11 | $808K |
| Carbamazepine Generic | 88 | 150 | 19 | $5,877 |
| Methotrexate Methotrexate Sodium | 88 | 188 | 21 | $2,084 |
Brand drugs: 647 claims; generic drugs: 4,883 claims; opioid claims: 260.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sharon G Lynch $219 ($219 in general payments such as food, travel and fees) from 12 companies. The largest payer was Vanda Pharmaceuticals Inc. with $81.79.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.